Literature DB >> 11535308

Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population.

E M Gardner1, E D Bernstein, S Dran, G Munk, P Gross, E Abrutyn, D M Murasko.   

Abstract

The effects of yearly influenza immunization on the level of antibody responses were assessed in 92 healthy elderly subjects immunized over four contiguous years (1993-1996) with a trivalent influenza vaccine that included A/Texas annually. Anti-A/Texas antibodies increased significantly and similarly post-vaccination each year, but returned to comparable baseline levels annually. Percentages of subjects with anti-A/Texas titers > or =40 post-vaccination were comparable over four years. Importantly, post-vaccination titers > or =40 to A/Texas in 1993-1994 predicted anti-A/Texas titers > or =40 in subsequent years. Thirty percent of individuals produced four-fold rises to any vaccine component the first year it was included in the vaccine, however, this percentage decreased to about 10% after subsequent vaccination with the same component. This study clearly supports the concept that annual immunization with the same influenza vaccine component over multiple years does not significantly decrease antibody titers in a healthy elderly population.

Mesh:

Substances:

Year:  2001        PMID: 11535308     DOI: 10.1016/s0264-410x(01)00246-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  18 in total

Review 1.  Age effects on B cells and humoral immunity in humans.

Authors:  Daniela Frasca; Alain Diaz; Maria Romero; Ana Marie Landin; Bonnie B Blomberg
Journal:  Ageing Res Rev       Date:  2010-08-20       Impact factor: 10.895

Review 2.  The unmet need in the elderly: how immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines.

Authors:  Janet E McElhaney; Xin Zhou; H Keipp Talbot; Ernst Soethout; R Chris Bleackley; David J Granville; Graham Pawelec
Journal:  Vaccine       Date:  2012-01-27       Impact factor: 3.641

3.  Vulnerability, distress, and immune response to vaccination in older adults.

Authors:  Suzanne C Segerstrom; Jaime K Hardy; Daniel R Evans; Richard N Greenberg
Journal:  Brain Behav Immun       Date:  2011-10-29       Impact factor: 7.217

4.  Comparison of complement dependent lytic, hemagglutination inhibition and microneutralization antibody responses in influenza vaccinated individuals.

Authors:  Mary Dawn T Co; John Cruz; Akira Takeda; Francis A Ennis; Masanori Terajima
Journal:  Hum Vaccin Immunother       Date:  2012-08-16       Impact factor: 3.452

5.  Trivalent influenza vaccine-induced antibody response to circulating influenza a (H3N2) viruses in 2010/11 and 2011/12 seasons.

Authors:  Satoshi Hiroi; Saeko Morikawa; Keiko Nakata; Akiko Maeda; Tsuneji Kanno; Shin Irie; Satoko Ohfuji; Yoshio Hirota; Tetsuo Kase
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 6.  Influenza vaccine responses in older adults.

Authors:  Janet E McElhaney
Journal:  Ageing Res Rev       Date:  2010-11-03       Impact factor: 10.895

Review 7.  Aging and inflammation: etiological culprits of cancer.

Authors:  Aamir Ahmad; Sanjeev Banerjee; Zhiwei Wang; Dejuan Kong; Adhip P N Majumdar; Fazlul H Sarkar
Journal:  Curr Aging Sci       Date:  2009-12

Review 8.  Aging affects human B cell responses.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  J Clin Immunol       Date:  2011-02-12       Impact factor: 8.317

Review 9.  Influenza and pneumococcal vaccinations for patients with chronic obstructive pulmonary disease (COPD): an evidence-based review.

Authors:  S Sehatzadeh
Journal:  Ont Health Technol Assess Ser       Date:  2012-03-01

10.  Natural killer cell development and maturation in aged mice.

Authors:  Eleni Beli; David M Duriancik; Jonathan F Clinthorne; Taehyung Lee; Sungjin Kim; Elizabeth M Gardner
Journal:  Mech Ageing Dev       Date:  2013-12-18       Impact factor: 5.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.